Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2

Documenti analoghi

• Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2
  di: Igor V. Krasilnikov, et al.
  Pubblicazione: (2022-01-01)
• Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
  di: Aleksandr V. Kudriavtsev, et al.
  Pubblicazione: (2023-02-01)
• Phase I Clinical Study of the Subunit Betulin-Adjuvanted Tetravalent Candidate Influenza Vaccine TetraFluBet
  di: Igor Krasilnikov, et al.
  Pubblicazione: (2024-09-01)
• Comparative Analysis of the Neutralizing Capacity of Monovalent and Bivalent Formulations of Betuvax-CoV-2, a Subunit Recombinant COVID-19 Vaccine, Against Various Strains of SARS-CoV-2
  di: Anna V. Vakhrusheva, et al.
  Pubblicazione: (2024-10-01)
• Morphology of Lymphoid Tissue in the Lungs of Guinea Pigs Infected with <i>Mycobacterium bovis</i> against the Background of Vaccine Immunity and the Action of Betulin and Its Derivatives
  di: Ivan N. Koshkin, et al.
  Pubblicazione: (2022-12-01)